glp-1 medication How medications are transforming diabetes and weight loss treatment How GLP-1 medications are transforming

Eligibility for a GLP-1 medication depends on a Service Members diagnosis, prior authorization, and/or medical necessity.Service Members who are overweight with other risk factors or obese should work with their Department of War (DoW) medical officer or Primary Care Manager/Provider to determine if a GLP-1 medication is appropriate before starting these medications.The use of GLP-1 medications during training, deployments, or operational platforms might not be authorized

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

Gastrointestinal side effects are a little more common in the oral version than in the injectables

The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans, pharmacy chains, and the federal government.